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Background: MicroRNAs (miRNAs) play a pivotal role in coordinating messenger RNA (mRNA) transcription and
stability in almost all known biological processes, including the development of the central nervous system. Despite
our broad understanding of their involvement, we still have a very sparse understanding of specifically how miRNA
contribute to the strict regional and temporal regulation of brain development. Accordingly, in the current study
we have examined the contribution of miRNA in the developing rat telencephalon and mesencephalon from just
after neural tube closure till birth using a genome-wide microarray strategy.
Results: We identified temporally distinct expression patterns in both the telencephalon and mesencephalon for
both miRNAs and their target genes. We demonstrate direct miRNA targeting of several genes involved with the
migration, differentiation and maturation of neurons.
Conclusions: Our findings suggest that miRNA have significant implications for the development of neural
structure and support important mechanisms that if disrupted, may contribute to or drive neurodevelopmental
disorders.
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The developing cerebral cortex is highly compartmental-
ized and involves precise regulation of cell proliferation,
migration and differentiation [1,2]. The behaviour of cells
undergoing these neurodevelopmental processes is gov-
erned by spatiotemporal changes in gene expression [3].
Translation and intracellular traffic of these transcripts is
influenced by small non-coding miRNA that function as
molecular guide sequences for ribonucleoprotein com-
plexes involved in targeted mRNA degradation or transla-
tional repression (reviewed [4-7]). By regulating mRNAs
post-transcriptional fate, miRNA subsequently play a sig-
nificant role in organizing complex patterns of gene activ-
ity. Thus these small RNA molecules also display distinct
expression profiles [8-10], and exhibit both temporal and* Correspondence: murray.cairns@newcastle.edu.au
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unless otherwise stated.spatial specificity [8,11-13]. For example, miR-9 has
been demonstrated to play a role in controlling neuro-
genesis timing via targeting of progenitor-promoting
and cell-cycle exit-promoting genes [14]. Accordingly,
its expression has been shown to increase during neu-
rodevelopment, but not in the postnatal period [11],
and to be regionally restricted to telencephalic, di-
encephalic and tectal periventricular proliferative zones
[12].
Analysis of miRNA and their target mRNA expression
in neuronal cell cultures supports a regulatory role for
miRNAs in neuronal development [15-18]. Consistent
with this role, a number of neural-specific or neural-
enriched miRNAs have been identified [19] and are
thought to be involved in regulating early brain develop-
ment (reviewed [20]). For example, miR-134 and miR-137
regulate neuronal maturation through the modulation of
their target mRNA. The brain-specific miR-134 regulates
dendritic spine development by repressing the translation
of an mRNA encoding a protein kinase, Limk1, that con-
trols spine development [21], while the brain-enriched
miR-137 has a significant role in neuronal maturation andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ubiquitin ligase important for neurogenesis and neurode-
velopment [22]. This supports existing evidence for the
role of miRNAs in neurogenesis [23], morphogenesis [24],
neuronal cell specification [25] and oligodendrocyte differ-
entiation and myelination [26].
In the current study we wanted to determine if miRNA
and their predicted targets are altered in accordance
with their developmental stage and neurodevelopmen-
tal regionalization. More specifically we compare devel-
opmental miRNA and gene expression in the caudal
regions including the mesencephalon and metencepha-
lon that develop relatively early, with more rostral areas
such as the telencephalon and diencephalon which de-
velop later [27], as we hypothesize that miRNA are the
subject of related spatiotemporal regulation. By matching
miRNAs with their inversely-regulated mRNA targets,
we suggest that miRNA’s post-transcriptional regulatoryFigure 1 miRNA expression profiles in the developing rat brain. Inten
development in the telencephalon (A) and mesencephalon (B). Each color
2.3 to 14.3 as indicated by color legend. Color legend is relative to E12 suc
blue while those with high expression at E12 (signal intensity of 14.3) are in
mesencephalon and telencephalon at each timepoint. Solid line = line of binfluence changes throughout neurodevelopment, with
a pattern of expression in the developing telencephalon
occurring after that of the mesencephalon in accord-
ance with their respective cytoarchitectural and synap-
tic maturity.
It is critical for the development and use of rodents as
animal models of neuropsychiatric disorders that we have
a good understanding of the nature and timing of regional
differentiation in the rodent brain. Predicting neurodeve-
lopmental events and recognizing differing windows of
vulnerability to environmental insults will help develop
clinically relevant experimental models.
Results
Temporal dynamics of miRNA expression in the
telencephalon and mesencephalon between E12 and P0
miRNA expression was analysed in the telencephalon
and mesencephalon of embryonic (E) (E12, E14, E15,sities of differentially expressed miRNA microarray probes across
ed line represents one probe. Normalized signal intensities range from
h that probes with low expression at E12 (signal intensity of 2.3) are in
red. (C) Scatter plots illustrating miRNA expression in the
est fit; R2 = Pearson correlation coefficient.
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GeneChip miRNA array matrices (Affymetrix). Data ana-
lysis revealed 303 miRNA in the telencephalon and 266 in
the mesencephalon with differential expression during
brain development. miRNA expression displayed greater
variation in the telencephalon (Figure 1A) compared to
the mesencephalon (Figure 1B) throughout development
(Figure 1C), with 97 miRNA in the telencephalon having
substantive temporal variance (SD > 1.3) across develop-
ment as compared to 38 miRNA in the mesencephalon.
There were also a number of miRNA with altered expres-
sion specific to the telencephalon. This occurred at E12
(32 miRNA) and E19 (26 miRNA) only. In contrast the
mesencephalon had no region-specific miRNA expression
at any time during the developmental timepoints exam-
ined. Furthermore we also observed stage-associated ex-
pression in the telencephalon-specific miRNA, with 13
and 7 expressed only at E12 or E19 respectively (Add-
itional file 1). To gain an appreciation of the biological im-
plications of these telencephalon-specific miRNA during
early telencephalon development, putative target genes of
the 32 miRNA specific to the telencephalon at E12 andFigure 2 Computational gene interaction predictions: network of E12
and other nervous system signalling pathways. A network of putative
structed with the Ingenuity Systems Pathway Analysis (IPA) software. Soli
dicate indirect interactions. Genes involved in select neurodevelopmentathe 26 miRNA specific to the telencephalon at E19 were
assessed for Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway enrichment using the Gene Annotation
Tool to Help Explain Relationships (GATHER) online
database. For the telencephalon-specific miRNA at E12 this
revealed a number of significantly enriched pathways with
relevance to neural connectivity and synaptic plasticity,
such as focal adhesion; adherens junction; oxidative phos-
phorylation; regulation of actin cytoskeleton and ECM-
receptor signalling. Similarly, the telencephalon-specific
miRNA at E19 were predicted to be enriched in the
Mitogen-activated protein (MAP) kinase signalling path-
way and Wingless/int (Wnt) signalling pathway (Additional
file 2). Further analysis using Ingenuity Pathway Analysis
(IPA) software (Ingenuity Systems) revealed roles in im-
portant neurodevelopmental processes including: the dif-
ferentiation of dopamine neurons; neuron and neuroglia
differentiation; myelination; synaptogenesis; and axonogen-
esis (Figure 2).
To determine those miRNA that were differentially
regulated with respect to developmental age, all miRNA
were ranked based on their temporal expression variancetelencephalon-specific miRNA involved in the Neurotransmitters
gene targets of the 32 telencephalon-specific miRNA at E12 was con-
d grey lines specify direct relationships whereas dotted grey lines in-
l processes are indicated with solid color lines.
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changes throughout development (SD > 1.3) were selected
for downstream analysis (Additional file 3). The 97
miRNA identified were found to have significantly lower
expression (F = 5.271, n = 12, p < 0.05) in theFigure 3 miRNA expression in the developing rat brain. (A) Expression
telencephalon and mesencephalon throughout development (for display pur
intensity values for all dynamic miRNAs at each developmental timepoint). Al
Tukey-Kramer’s post hoc t-testing (* = p < 0.05). (B & C) Relative expression lev
hierarchically clustered (supervised, correlation uncentred, average linkage; Clu
jtreeview.sourceforge.net). Two major clusters are shown in six columns corre
telencephalon and mesencephalon miRNA for each cluster is shown adjacen
ANOVA, followed by Tukey-Kramer’s post hoc t-test. *** = p < 0.001.telencephalon compared to the mesencephalon at embry-
onic day 14 (Figure 3A). Supervised hierarchical clustering
of these miRNA was characterized by distinct expression
clusters, two of which showed significantly lower expres-
sion (p < 0.001) in the telencephalon compared to theof the 97 miRNA showing strong developmental regulation in the
poses expression was derived by calculating the geomean of signal
l data were analysed for significance by one-way ANOVA, followed by
els for the 97 miRNA showing strong development regulation were
ster 3.0). Colors indicate relative signal intensities. (Java Treeview; http://
sponding to the six time points. Comparison of expression of
t to the heatmap. All data were analysed for significance by one-way
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Prominent among this group were miRNAs that are
enriched in neurons and associated with developmental
regulation (let-7i, let-7f, let-7b, miR-98), cell cycle regula-
tion (miR-137, mIR-128) and neural activity (miR-132,
miR-212). Bioinformatic analysis of these 97 miRNA
through IPA (Ingenuity Systems) identified 9652 putative
miRNA target genes. Gene ontology (GO) function and
KEGG pathway enrichments were performed by mapping
the predicted target genes from the developmentally regu-
lated miRNAs using the GATHER online database. For
these miRNAs and their predicted targets, 22 GO func-
tions and 3 KEGG pathways were significant (Bayes fac-
tor >6). The top ontologies included: regulation of cell
cycle; development; morphogenesis; regulation of tran-
scription; and neurogenesis (Additional file 4).
In summary, while we observed substantial overlap be-
tween miRNA expressed in the telencephalon and mesen-
cephalon, there was a number of functionally significant
miRNA expressed exclusively in the telencephalon. From
longitudinal analysis in each brain region, it was also ap-
parent that telencephalon miRNA expression was subject
to more temporal variation compared to the mesenceph-
alon. Genes predicted to respond to this developmental
variation in telencephalon cortical miRNA expression
were enriched in pathways associated with neural develop-
ment and function.
Developmental regulation of mRNA expression in the
telencephalon and mesencephalon between E12 and P0
mRNA expression was analysed in the telencephalon
and mesencephalon of embryonic (E12, E14, E15, E18,
E19) and newborn (P0) rats using RatRef-12 Expression
BeadChips (Illumina). Data analysis revealed a total of
16,691 genes with differential expression during neural
development (E12-P0), comprised of 14,371 genes in the
telencephalon and 13,906 genes in the mesencephalon.
To determine those genes that were differentially regu-
lated with respect to developmental age, all mRNA were
ranked based on their temporal expression variance be-
tween E12 to P0. Those that demonstrated the greatest
variation throughout development (SD >3.2) were selected
for bioinformatic evaluation (Additional file 5). These 100Table 1 Network analysis using IPA
Associated Network Functions
Cell-To-Cell Signalling and Interaction, Nervous System Development and Fu
Cellular Growth and Proliferation, Haematological System Development and
Cellular Development, Cell Signalling, Organ Development
Cell Morphology, Cellular Function and Maintenance, Cell Cycle
Psychological Disorders, Cell Death, Gene Expression
Network analysis using IPA (Ingenuity Systems) for predicting potential interactions
differentially expressed miRNA.genes with high temporal expression dynamics were fur-
ther assessed for their involvement in biological pathways.
GO function and KEGG pathway enrichment of these
genes revealed 43 significant (p < 0.05) GO functions and
1 KEGG pathway (Additional file 6). Network analysis
using IPA (Ingenuity Systems) for predicting potential in-
teractions between the differentially expressed genes gen-
erated three networks with the highest IPA analysis scores
(47, 25 and 21) including Cell-To-Cell Signalling and
Interaction; Nervous System Development and Function;
Cellular Growth and Proliferation; and Cellular Develop-
ment (Table 1). While these biological processes accorded
well with those predicted by the developmentally regu-
lated miRNA, we wanted to explore the possibility that
these 100 dynamically expressed genes were most likely
responding to changes in miRNA expression and driving
developmentally significant changes in cell morphology
and physiology, by bioinformatically associating the puta-
tive interactions with observed changes in predicted rela-
tionships or miRNA-mRNA interactions.
miRNA-mRNA interactions
Given that miRNAs predominantly function to negatively
regulate gene expression, we examined the biological sig-
nificance of inverse expression patterns between differen-
tially expressed miRNA and differentially expressed genes
in the telencephalon during development. We used Inge-
nuity’s miRNA Target Filter® to analyze all possible
miRNA and target-gene interactions from the miRNA and
gene expression array data sets. The results were filtered
based on the confidence of interaction and an inverse
miRNA to target mRNA relationship. These gene sets
were then functionally annotated using the Database for
Annotation, Visualization, and Integrated Discovery bio-
informatics resources 6.7 (DAVID) online database, re-
vealing significant over-representation in neural pathways
throughout development. This included axon guidance,
neuroactive ligand-receptor interaction, MAP kinase sig-
nalling, Wnt signalling, long-term depression and calcium
signalling (Additional file 7).
We further investigated the putative roles of mir-98, mir-
212 and mir-137 in the development of the telencephalon.
All three miRNA were determined to be dynamicallyScore





between the differentially expressed genes potentially regulated by
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telencephalon expression between E12 and E19. These
neuronally important miRNAs have critical roles in neuro-
development and are associated with neuropathology (see
Discussion). Concordantly, their predicted gene targets were
also highly significant in our study. Validation of microarray
expression for these three miRNA using quantitative real-
time reverse transcription PCR (Q-PCR) (Figure 4) con-
firmed significantly lower expression in the telencephalon
compared to the mesencephalon at E12. To further investi-
gate their biological relevance, IPA software was used to
identify putative differentially expressed target genes ofFigure 4 Select miRNA expression in the developing rat brain. Total R
E15, E18, E19 and P0, amplified, labelled and hybridised to Affymetrix Genech
analysed using GeneSpring GX11. Figures show the normalised signal intensit
developmental stage in the mesencephalon and telencephalon (*** = p < 0.0
fold-change. Mean value of E12 was set to 1-fold induction, and mean values
by microarray appears as black bars and Q-PCR results appear as white bars. For
by the difference between their individual cycle threshold (Ct) value and that
represent standard deviation of the means. Microarray expression data was va
correlation coefficients of 0.64 (C), 0.62 (F) and 0.69 (I) respectively.these dynamically regulated miRNA. Analysis of this gene
dataset using the DAVID online database revealed signifi-
cant (p < 0.05) over-representation of neurodevelopmental
functions in the mammalian forebrain cortex, including
axonogenesis; neuron projection development; synaptic
transmission; forebrain development; regionalization; and
learning and behaviour (Additional file 8).
Target gene silencing in vitro
Our expression analysis of miRNA and their cognate
mRNA targets suggested that there are a tremendous
number of interactions that underlie the spatiotemporalNA was isolated from rat telencephalon and mesencephalon at E12, E14,
ip miRNA 1.0 microarrays. Data were normalised using cubic spline and
y values for miR-98 (A) and miR-212 (D) and miR-137 (G) at each
01). Findings were validated by Q-PCR and data expressed as a
of all other ages were related to E12. MiRNA expression as determined
Q-PCR, relative miRNA expression in the telencephalon was determined
produced in the same sample for the U6 snRNA (ΔCt). Error bars
lidated by RT-PCR for miR-98 (B), miR-212 (E) and miR-137 (H) with
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to further support the functional association between
neural development-associated target genes and altered ex-
pression in this group of miRNAs, the respective miRNA
recognition elements (MRE) from a selection of six func-
tionally significant target genes, Clasp2, Rab15, Cbll1,
Wnt7a, Gpr88 and Plxnb2, were cloned into the 3’ un-
translated region (UTR) of a luciferase reporter gene
construct and co-transfected into a recipient cell line
with synthetic miRNA mimics corresponding to those
altered in vivo. The degree of reporter gene activity and
the impact of miRNAs were then ascertained by meas-
uring the relative luciferase activity (Figure 5). MiRNAs
interact with their respective MREs in the 3’UTR of tran-
scripts and each gene may contain binding sites for mul-
tiple miRNA. Therefore observing miRNA-mediated effects
using a reporter gene construct allows subtle changes
in gene expression to be observed. Most of the reporter
constructs behaved in accordance with expectation and
were repressed 8-25% (p < 0.05) in the presence of syn-
thetic miRNA in comparison to a scrambled-duplex co-
transfected control. These data indicate that transfected
miRNAs bound to their target MREs and repressed the
expression of luciferase, with the most responsive tar-
gets derived from the 3’-UTR of Wnt7a and Gpr88.
These were both targeted by miR-137, which appeared
to have the greatest overall effect, whereas miR-212 had
the least effect on these target gene constructs. The
only exception was the Plxnb2 construct, which dis-
played increased expression in the presence of synthetic
miR-137. Collectively, these reporter assays supported
the existence of relationships between genes reported
to be associated with neural development and develop-
mentally regulated miRNAs.Figure 5 Regulation of neuronal development-associated reporter ge
gene constructs (x-axis) in response to co-transfected miRNAs. Relative luci
a percentage of the response to scrambled controls. Bars are mean ± SEM.Discussion
miRNA and post-transcriptional regulation of
neurodevelopment
The trajectory of human brain development closely mir-
rors that seen in the rodent [28] and as such the rat of-
fers an excellent model to investigate the coordination
and timing of miRNA expression across fetal develop-
ment. In the current study we examined the expression
profiles of miRNA within the mesencephalon and telen-
cephalon from E12 until birth. We hypothesized that the
developing telencephalon would exhibit a significantly
different temporal miRNA profile in relation to the mes-
encephalon and this was supported by the observation
that 87% of expressed miRNA underwent significant
change across development, with clear differences in
patterning between the two regions. The highest level of
change in miRNA expression occurred early in develop-
ment (E12-E15) and plateaued thereafter, with differ-
ences between the telencephalon and mesencephalon
decreasing noticeably during that time period. In accord-
ance with our hypothesis, telencephalon miRNA expres-
sion was significantly lower than the mesencephalon at
E12 and consistent with the delayed development of this
region. We also observed 32 miRNA with predicted
function in neurodevelopmental processes, exclusively
expressed in the telencephalon during early brain devel-
opment (E12).
We then employed a bioinformatics approach to further
understand the differential developmental trajectories of
these two brain regions. Temporally regulated miRNAs
and genes were examined using a combination of miRNA
and gene expression profiling and computational target
prediction. Hierarchical clustering of miRNA during tel-
encephalon development revealed two distinct clusters ofne constructs by miRNA. Chart shows relative activity of reporter
ferase activity for each reporter/miRNA combination was expressed as
(** = p < 0.01, * = p < 0.05).
Hollins et al. BMC Genomics 2014, 15:777 Page 8 of 13
http://www.biomedcentral.com/1471-2164/15/777miRNA. These clusters had significantly higher expression
in the mesencephalon at E12 whilst expression in the tel-
encephalon remained significantly lower (Figure 3B & C).
The miRNA contained in these clusters are predicted to
target temporally-regulated genes involved in brain signal-
ling pathways important for neurodevelopment and neur-
onal functioning including: dopamine receptor signalling;
GABA receptor signalling; glutamate receptor signalling
and neuroactive ligand-receptor interactions. As expres-
sion of the neuroactive ligand-receptor interactions path-
way is demonstrated to correlate with synaptic maturity
[29], this data is consistent both with the telencephalon
being less differentiated at this time point and more im-
portantly implicates a critical role for miRNA in this
process. This also indicates that at such an early time-
point, the developing telencephalon may be largely un-
affected by environmental insults compared to the
mesencephalon. This may be particularly relevant for cer-
tain developmental animal models of disease. For instance
the widely used maternal immune activation model of
schizophrenia employs the artificial viral construct poly I:
C which induces a strictly time-limited inflammatory re-
sponse of approximately two days in the maternal animal
[30]. This may be why when it is commonly administered
at E9 in mice (equivalent to E10 in a rat), the downstream
effects may be restricted to the developing mesencephalon
rather than later maturing regions such as the telenceph-
alon [31].
miRNA-mRNA interactions
While there are some exceptions, miRNA function is
usually associated with repression of target gene expres-
sion, such that when a miRNA is expressed at high
levels, its target mRNA is reduced [32-34]. Indeed, sev-
eral reports have identified inverse expression patterns
between differentially expressed miRNA and differen-
tially expressed mRNA during development [17,18]. In
this study we found the putative down-regulated gene
targets of up-regulated miRNA in the telencephalon be-
tween E12 and E14 are predicted to be involved in many
important brain signalling pathways including axon
guidance, neuroactive ligand-receptor interaction, cal-
cium signalling and long-term depression.
Altered expression of miRs-98, −212 and −137 was
particularly noteworthy, as these three neuronally im-
portant miRNAs were much more abundant in develop-
ing mesencephalon than telencephalon at the earliest
embryonic age showing more than a three-fold increase
in telencephalon expression between E12 and E19. All
three miRNA have critical roles in neurodevelopment
and are associated with neurological disorders such as
Alzheimer’s disease and schizophrenia. We confirmed a
functional link between these three miRNA and suppres-
sion of expressed target genes by cloning the MREs fromClasp2, Rab15, Cbll1, Wnt7a, Gpr88 and Plxnb2 down-
stream of a luciferase reporter gene. These reporter con-
structs were then co-transfected with synthetic analogues
of their cognate miRNA into a recipient cell line, such that
the extent of reporter gene expression and therefore the
influence of miRNA could be ascertained through the
measurement of relative luciferase activity (Figure 5).
Most of these constructs were significantly repressed in
the presence of synthetic miRNA. In particular, regulation
of 3’-UTR elements from Wnt7a (miR-137) and Gpr88
(miR-137) was particularly strong and, along with Clasp2
(miR-98) and Rab15 (miR-212) provides support for the
role of post-transcriptional regulation in axon and den-
dritic growth, maturation and function [35-38]. Path-
way analysis of these target genes indicated that these
miRNA may exert significant influence during neurode-
velopment through the regulation of pathways including:
axon guidance; neuroactive ligand-receptor interaction;
Wnt; Erythroblastic Leukemia Viral Oncogene Homolog
(ErbB); and MAP kinase signalling.
In the telencephalon, expression levels of miR-98 in-
creased over four-fold between E12 and E19, a similar
finding to that of Sempere and colleagues [15], who
found mir-98 expression levels progressively accumu-
lated upon neuronal differentiation in both mouse and
human embryonic carcinoma cells. Experiments by
Thomson and colleagues [39] similarly found levels of
miR-98 were significantly increased in mice at E14.5
compared to levels in embryonic stem cells. Mir-98 is a
member of the let-7 family, highly conserved across spe-
cies in sequence and function and involved in the devel-
opmental timing of cell fates (reviewed [40]). In support
of a role for miR-98 in telencephalon development, mir-
98 overexpression was found to significantly decrease
the activity of a luciferase reporter gene fused to the
cytoplasmic linker associated protein 2 (Clasp2) 3’-UTR.
Clasp2 plays a crucial role in chromosome segregation
during mitosis [41] and is a key regulator of neuronal
morphogenesis, neuronal polarity and synapse formation
and activity [37].
Similarly, the results suggest a role for miR-212 in
brain development with expression levels increased
more than four-fold in the telencephalon between E12
and birth. MiR-212 arises from the miR-212/132 cluster,
which is highly conserved in vertebrates. MiR-212 and
miR-132 are tandem miRNAs with similar target specifi-
city due to their identical seed sequences. In the brain,
miR-212 and miR-132 play vital roles in the formation
and plasticity of neuronal connections, and long-term
synapse activation (reviewed [42,43]). Dysregulation of
miR-212 is associated with drug addiction [44], neuro-
pathological disorders [43] and schizophrenia [45]. Our
luciferase reporter assays support miR-212 involvement
in neurodevelopment via regulation of Rab15, member
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like 1, E3 ubiquitin protein ligase (Cbll1). Rab15 belongs
to the Rab family of low molecular weight (LMW) GTP-
binding proteins, crucial in ensuring the spatiotemporal
regulation of membrane traffic [46]. Rab15 is enriched
in neural tissue and plays a role in regulating neuro-
transmitter release [47]. Cbll1 is a RING finger type E3
ubiquitin ligase and an important regulator of cell prolif-
eration [48]. In Drosophila, Cbll1 is required for proper
function of cell surface proteins and for endoderm and
mesoderm morphogenesis [49]. Consistent with the in-
crease of miR-212 expression between E12 and E19,
Cbll1 function is demonstrated to be most vital in the
early stages of embryogenesis, with its contribution de-
clining in later stages [49].
Another developmentally regulated miRNA is miR-
137, with expression levels increasing more than four-
fold in the telencephalon between E12 and E19. Mir-137
is enriched in neurons and involved in neuronal matur-
ation, regulation of dendritic development and pheno-
typic maturation of new neurons [22]. Recent studies
demonstrate increasing expression of miR-137 during
neuronal differentiation, leading to reduced neural stem
cell proliferation, accelerated neural differentiation and
decreased dendritic development [22,50]. Dysregulation
of miR-137 has been associated with intellectual disabil-
ity and Alzheimer’s Disease [51,52] and the MIR137 gene
has also recently found to be highly associated with
schizophrenia in a genome wide screen and associated
with cognitive function in patients with the disorder
[53,54]. This study confirmed the potency of miR-137 to
down-regulate G-protein coupled receptor 88 (Gpr88)
and wingless-type MMTV integration site family, mem-
ber 7A (Wnt7a) using a reporter gene strategy. Gpr88 is
a brain-enriched G protein–coupled receptor with a role
in modulating the striatal dopaminergic system [55] and
in regulating medium spiny neuron excitability [38].
Wnt7a signalling is critical to regulate dendritic spine
growth and synaptic strength [35], mediating synapse
density and numbers, and hippocampal network struc-
ture [56]. During development Wnt signalling is re-
quired for cell proliferation and differentiation, cell
polarity generation and embryonic patterning.
As various brain regions develop at different times
there is likely to be differing windows of vulnerability to
environmental insults. Appropriate spatiotemporal ex-
pression of miRNA is vital during brain development
and dysregulation during sensitive stages is likely to have
a profound impact on the coordinated expression of de-
velopmentally significant genes associated with the
pathophysiology of neuropsychiatric disorders. This is
supported by the alterations of miRNA expression ob-
served in the neuropathology of Alzheimer’s disease
[51], Huntington’s disease [57,58], Parkinson’s disease[59-61] and schizophrenia [62,63]. Understanding the
role of miRNA in brain ontogeny could identify critical
windows of developmental significance that are suscep-
tible to environmental insults which contribute to the
development of neurobehavioural or neuropsychiatric
syndromes.
Conclusions
This study represents the first global characterization of
both miRNA and mRNA expression between the telen-
cephalon and mesencephalon at various stages during de-
velopment in rodent brain. Comparing the telencephalon
and mesencephalon affords a molecular basis for under-
standing the nature and timing of regional differentiation.
Although these results may have been hypothesised based
on current evidence suggesting that the mesencephalon
develops earlier than the telencephalon, the present data
now provide direct molecular support that differential re-
gional and temporal miRNA expression within the brain
is part of this process. Knowledge of the temporal and
spatial expression profiles of miRNA and their target
genes is an important initial step in elucidating their func-
tions. Together these results show that miRNA expression
is frequently region- and time-specific with an important
influence in functionally relevant pathways in the develop-
ing brain.
Methods
RNA preparation and analysis of integrity
Telencephalon and mesencephalon were dissected from
brains of embryonic (E) (E12, E14, E15, E18, E19) and
newborn (P0) rats. Each time point represents a pooled
litter of rat embryos (n = 8-12). Animals were handled in
accordance with the University of Queensland's animal
care and ethics committee approval, in compliance with
the current Australian Law. Total RNA was isolated from
the telencephalon and mesencephalon using TRIzol re-
agent as described previously [64]. RNA concentration, in-
tegrity and purity were assessed using the Agilent 2100
Bioanalyser (Agilent Technologies). RNA Integrity Num-
bers (RIN) were automatically calculated with the pro-
vided system software [65]. All samples showed RIN
values superior to 8.5.
MicroRNA expression profiling
For miRNA profiling, total RNA (700-1000 ng) was
labelled using a FlashTag Biotin HSR RNA labelling kit
according to manufacturer’s instructions (Genisphere).
Labelled RNA was hybridised to the Affymetrix Genechip
miRNA 1.0 microarrays (miRBase version 11.0) for
16 hours at 48°C and 60 rpm in a hybridisation oven (Affy-
metrix) and washed and stained with the Fluidics Station
450 (Affymetrix). Hybridisation, wash and stain reagents
were from the Hyb, Wash and Stain kit (Affymetrix).
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3000 7G. Differential miRNA expression was analysed
using GeneSpring GX 11.0 (Agilent Technologies) and was
assessed as having a minimum 2-fold difference in either
direction between two time-points. To determine those
miRNA that were differentially regulated with respect to
developmental age, the standard deviation of each miRNA
across development (E12-P0) was calculated. MiRNA with
a standard deviation of >1.3 were considered to be devel-
opmentally regulated.
mRNA expression profiling
Total RNA was prepared for microarray using the RNeasy
Mini Kit (Qiagen) and amplified with the Illumina Total-
Prep RNA Amplification Kit (Ambion). Microarrays were
performed using the Illumina Rat-Ref-12_V1 Expression
BeadChip, following the manufacturer's instructions, and
scanned using the Illumina BeadArray Reader and BeadS-
can software (Ambion, Scoresby, VIC, Australia). Bead
summary data were normalized in GenomeStudio v3
(Illumina) using Cubic Spline. Differential mRNA ex-
pression was analysed using GeneSpring GX 11.0 (Agilent
Technologies) and was assessed as having a minimum 2-
fold difference in either direction between any two time-
points.
Target gene and pathway analyses
miRNAs that were determined to be differentially
expressed were further analysed for putative target genes
under their influence using Ingenuity® microRNA target
filter [Ingenuity® Systems (www.ingenuity.com)]. Pathways
and gene ontology enrichment analysis of the target
genes was performed using the DAVID (http://david.
abcc.ncifcrf.gov/) [66,67] and GATHER (http://gather.
genome.duke.edu/) [68] online databases. To further in-
vestigate biologically relevant targeting, differential
miRNA and mRNA expression data was analyzed through
the use of Ingenuity® microRNA target filter to generate
lists of interactions between genes and miRNAs. Results
were filtered based on a high confidence of interaction
and an inverse miRNA to target mRNA expression rela-
tionship. The identified genes were then subjected to
pathways and gene ontology enrichment analysis.
Quantitative real-time reverse transcription PCR
Validation of differentially expressed miRNA was per-
formed by Q-PCR on a subset of the differentially
expressed miRNA. Briefly, 500 ng of sample RNA was
treated with DNase-I (Invitrogen), and multiplex reverse
transcription was performed with Superscript II reverse
transcriptase (Invitrogen), a 3 nmol/L mix of miRNA se-
quence specific primers and primers for U6 small nu-
clear RNA. The primer sequences for the amplification
of specific primers were as follows: rno-miR-98 - 5′-GTAAAACGACGGCCAGTAACAATA-3′ (forward), 5′-
TGAGGTAGTAAGTTG-3′ (reverse); rno-miR-212 - 5′-T
AA+CAGTCTCCAG-3′ (forward), 5′-GTAAAACGACG
GCCAGTCTACGCG-3′ (reverse); rno-miR-137 - 5′-TT +
ATT +GCTTAAGAATA-3′ (forward), 5′-GTAAAAC-
GACGGCCAGTCTACGCG-3′ (forward); U6 snRNA
5′-TGCTTCGGCAGCACATATAC-3′ (forward), 5′-A
GGGGCCATGCTAATCTTCT-3′ (reverse). Triplicate re-
actions were set up in a 96-well format with the epMotion
5070 automated pipetting system (Eppendorf, Hamburg,
Germany) and carried out with the Applied Biosystems
(Foster City, California) 7500 real-time PCR machine.
Relative quantification was assessed using the formula 2-
ΔCT. The delta Ct was calculated by subtracting the Ct of
the endogenous control (geometric mean of U6 small nu-
clear RNA (snRNA)) from the Ct of the miRNA.
Reporter construction
To generate reporter vectors bearing binding sites for
the three miRNA examined in detail, miR-98, miR-212
and miR-137, oligonucleotides encoding target gene
miRNA recognition elements (MREs) were annealed to
form SpeI and HindIII restricted overhangs of a ligatable
cassette compatible with SpeI and HindIII digested
pMIR-REPORT vector (Ambion, Austin, TX) as de-
scribed previously [69,70]. Recombinant reporter con-
structs were amplified in chemicompetent DH5alpha
Escherichia coli bacteria cells (Bioline, Sydney) and puri-
fied using endotoxin free minipreps (Promega, Madison,
WI) before being verified by DNA sequencing (AGRF,
St. Lucia, QLD, Australia) and quantitated using a Nano-
Drop 2000 (Thermo Scientific, Delaware, ME, USA).
Cell culture
Human embryonic kidney (HEK)-293 cell cultures were
maintained as confluent monolayers at 37°C with 5%
CO2 and 90% humidity in Dulbecco’s modified Eagles
medium (DMEM) with 10% (vol/vol−1) fetal calf serum,
20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid), 0.15% (wt/vol−1) sodium bicarbonate and
2 mM L-glutamine.
Transfection
For the luciferase assay, HEK-293 cells were seeded into a
96-well plate at a density of 20,000 cells per well and
transfected 24 h later using Lipofectamine 2000 (Invitro-
gen). In each case transfections were performed according
to the manufacturer’s instructions, with 100nM synthetic
miRNA (Invitrogen). Validation of predicted target
genes was accomplished by co-transfecting HEK293
cells with synthetic miRNA and recombinant firefly lu-
ciferase reporter gene constructs containing 3’-UTR se-
quences substituted from the target gene. Each reaction
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once. To validate the putative MREs, the HEK293 cell
line, which is of embryonic origin and easily transfected,
was an ideal candidate for the investigation of the func-
tional regulation of miRNA. Candidate genes were se-
lected based on: their inverse expression respective to
their targeting miRNA; their role in neurodevelopment
and association with neuropathology; a high MRE-binding
specificity score using the miRanda online software [71]
(Clasp2 – 142; Rab15 – 158; Cbll1 – 161; Wnt7a – 149;
Gpr88 – 150; Plxnb2 – 161).Reporter gene assay
Twenty-four hours after transfection, cells were har-
vested in 100 ml Passive Lysis Buffer (Promega, Madi-
son, WI) and 10 ml lysate was used to measure the
relative luciferase activity using the dual-luciferase re-
porter assay kit (Promega, Madison, WI). Reporter gene
silencing in response to miRNA co-transfection was
monitored with respect to a pRL-TK control plasmid ex-
pressing renilla luciferase using a Synergy plate reader
with dual reagent injector (Biotek). To control for the
nonspecific effects associated with transfection, the con-
trols were co-transfected with mutant miRNAs or mu-
tant anti-miRs (Invitrogen).Statistical analysis
Statistical significance analysis was assessed using one-way
or two-way analysis of variance (ANOVA) with Benjamini
Hochberg multiple comparisons testing (Prism software
version 5.0; GraphPad Software Inc., San Diego, CA). A
value of p < 0.05 was considered significant. The Tukey-
HSD test with a level of significance set at p < 0.05 was
used for post hoc comparisons. Unsupervised hierarchical
clustering was performed in Cluster (Stanford University,
Palo Alto, CA, USA) [72]. Data were log transformed and
median centred by genes. Genes and arrays were clus-
tered, correlation uncentred, by average linkage clustering
and visualized through Java Treeview V.1.1.6r2 (http://
jtreeview.sourceforge.net) [73]. Statistical comparison of
luciferase data sets was performed by two-tailed paired
Student’s t-test.Additional files
Additional file 1: A table listing miRNA expressed in the
telencephalon but not the mesencephalon at E12 and at E19. Also
listed are miRNA that are specific to the telencephalon at E12 only and at
E19 only.
Additional file 2: A table listing putative pathways regulated by
the E12 and E19 telencephalon-specific miRNA. Enriched pathways of
putative target genes of the 32 miRNA specific to the telencephalon at
E12 and the 26 miRNA specific to the telencephalon at E19 were
identified using the GATHER online database. Putative gene targets wereidentified using IPA. Only those pathways and ontologies with a Bayes
factor >6 were considered significant.
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miRNA. Also listed are the standard deviation values for each miRNA in
both the forebrain and midbrain.
Additional file 4: A table listing enriched ontologies of putative
target genes of the 97 dynamically regulated miRNA identified
using the GATHER online database. Putative gene targets were
identified using IPA. Only those pathways and ontologies with a Bayes
factor >6 were considered significant.
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mRNA. Also listed are the standard deviation values for each mRNA in
both the forebrain and midbrain.
Additional file 6: A table listing enriched ontologies of the 100
dynamically regulated miRNA identified using the GATHER online
database. Only those pathways and ontologies with a Bayes factor >6
were considered significant.
Additional file 7: A table listing enriched pathways of differentially
expressed miRNA targeting differentially expressed RNA identified
using the DAVID online database. Only those pathways with a p-value
<0.05 were considered significant.
Additional file 8: A table listing predicted ontologies enriched with
target genes of miRs-98, −212 andX −137. Enriched ontologies of
putative target genes of miR-98, miR-212 and miR-137 were identified
using the DAVID online database. Putative gene targets were identified
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